Characterizing Clinical and Pharmacological Neuroimaging Biomarkers
United States143 participantsStarted 2013-04-01
Plain-language summary
This study is part of a larger overall study that seeks to characterize clinical and pharmacological neuroimaging biomarkers. The purpose of this registered protocol is understand the effect of emotion on cognitions by specifically examining the effect of reward processing on working memory in patients with schizophrenia.
Who can participate
Age range16 Years ā 60 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* For BOTH Non-Healthy Controls and Healthy Controls:
* Right-handed as determined by the Edinburgh handedness questionnaire (Oldfield, 1971).
* Premorbid IQ\>70 determined by WAIS similarities and matrix reasoning subtests; Any history indicating learning disability, mental retardation, or attention deficit disorder will exclude the subject from participation.
* Must speak or read English at least 8th grade level or higher and to complete study evaluations.
* Must have intact vision or vision that can be corrected by glasses or contact lenses (corrected 20 20/20).
* Must be able to tolerate enclosed spaces \*\* only if participating in MRI portion.
* Female subjects must be postmenopausal for a least 1 year, surgically sterile, or using a reliable method of contraception at screening. Reliable methods of contraception include double-barrier methods (e.g. condom and diaphragm, condom and foam, condom and sponge), intrauterine devices, or hormonal birth control methods. Women with positive serum pregnancy results at screening or self-reporting of pregnancy will be excluded from the study. \*\* only if participating in MRI portion.
* Must be free of metallic foreign objects in body, such as aneurysm clips or pacemakers, or a questionable history of metallic fragments \*\* only if participating in MRI portion.
* For Non-Healthy Controls Participants:
* Adult patients from the community meeting diagnostic criteria for schizophrenia, schizoaffective disorder, ā¦